The Japan axillary hyperhidrosis treatment market is experiencing significant growth, with projections indicating a rise from USD 66.9 million in 2025 to USD 134.1 million by 2035, reflecting a CAGR ...

Some individuals sweat excessively compared to others, to the extent that their clothes become drenched. This excessive ...

Some individuals sweat excessively compared to others, to the extent that their clothes become drenched. This excessive ...

The India axillary hyperhidrosis treatment market is on a strong growth trajectory, projected to expand at a CAGR of 10.1%, rising from USD 75.2 million in 2025 to USD 196.8 million by 2035. This ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum ...

"Hyperhidrosis" is the medical term used to describe excessive sweating. To find the correct treatment, people must first pinpoint the cause. It can be driven by several things, including hormonal ...

Some people sweat excessively as compared to others. This condition, called hyperhidrosis, causes discomfort as the body produces more sweat than required, even without heat or exertion.

The treatment of hyperhidrosis varies by the cause. If hyperhidrosis is secondary to an underlying condition, the focus would be placed on treating the disorder rather than the sweating. In some cases ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...